Bill Snyder Archive — Page 29 of 119
-
November 17, 2022
Several from VUMC among most highly cited researchers
Nine current faculty members of the Vanderbilt University School of Medicine have made this year’s list of scientists whose papers have been cited most frequently by other researchers. -
November 10, 2022
Gastric Cancer Foundation funds Eunyoung Choi research
The Gastric Cancer Foundation has awarded a one-year $100,000 research grant to Eunyoung Choi, PhD, to support her efforts to find a way to disrupt the transformation of dysplastic stem cells into stomach cancer. -
November 10, 2022
AstraZeneca VP to discuss COVID-19 collaboration with VUMC Nov. 17
On Thursday, Nov. 17, Mark Esser, PhD, vice president, Early Vaccines and Immune Therapies R&D at AstraZeneca, will discuss his company’s collaboration with Vanderbilt University Medical Center that led to development of the Evusheld antibody combo to prevent COVID-19 in high-risk individuals. -
November 10, 2022
Hawiger still blazing a trail in inflammation research
Vanderbilt research describes a new investigational peptide drug that can penetrate immune and nonimmune cells, and block inflammatory signaling in a preclinical model of atopic dermatitis — eczema. -
November 10, 2022
Study defines role of steroids in congenital heart disease surgery
Steroids are commonly given to infants during open-heart surgery to reduce inflammation, but whether the drugs significantly improve patient outcomes has not been settled — until now. -
November 4, 2022
Study finds Moderna’s COVID-19 vaccine safe and effective for young children
A Vanderbilt study finds that Moderna’s COVID-19 vaccine is safe and effective in children 6 months to 5 years of age.